Cargando…

Drug Conjugates for Targeting Eph Receptors in Glioblastoma

Glioblastoma (GBM) is a complex and heterogeneous tumor that warrants a comprehensive therapeutic approach for treatment. Tumor-associated antigens offer an opportunity to selectively target various components of the GBM microenvironment while sparing the normal cells within the central nervous syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Puja, Roberts, Callie, Herpai, Denise, Fokt, Izabela D., Priebe, Waldemar, Debinski, Waldemar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243104/ https://www.ncbi.nlm.nih.gov/pubmed/32340173 http://dx.doi.org/10.3390/ph13040077

Ejemplares similares

Simultaneous targeting of Eph receptors in glioblastoma
por: Ferluga, Sara, et al.
Publicado: (2016)

Multireceptor targeting of glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020)

Receptor-Targeted Glial Brain Tumor Therapies
por: Sharma, Puja, et al.
Publicado: (2018)

IL13RA2 targeted alpha particle therapy against glioblastomas
por: Sattiraju, Anirudh, et al.
Publicado: (2017)

The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment
por: Sanders, Stephanie, et al.
Publicado: (2021)

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model
por: Pająk, Beata, et al.
Publicado: (2021)

Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
por: Sanders, Stephanie, et al.
Publicado: (2020)

Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells
por: Kim, Teddy E., et al.
Publicado: (2021)

Eph receptors as therapeutic targets in glioblastoma
por: Day, B W, et al.
Publicado: (2014)

Effect of structural modification at the 4, 3′, and 2′ positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells
por: Gruber, Beata M., et al.
Publicado: (2007)

Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
por: Rossmeisl, John H, et al.
Publicado: (2020)

Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
por: Rodriguez, Analiz, et al.
Publicado: (2015)

Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment—An Update
por: Gawel, Agata M., et al.
Publicado: (2022)

Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation
por: Olbryt, Magdalena, et al.
Publicado: (2017)

The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses
por: Pająk, Beata, et al.
Publicado: (2022)

A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2011)

Canine Butterfly Glioblastomas: A Neuroradiological Review
por: Rossmeisl, John H., et al.
Publicado: (2016)

Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing
por: Stuart, Christopher H, et al.
Publicado: (2016)

Peptide-based PET imaging of the tumor restricted IL13RA2 biomarker
por: Sai, Kiran Kumar Solingapuram, et al.
Publicado: (2017)

New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
por: Debinski, Waldemar, et al.
Publicado: (2013)

miR-30 Disrupts Senescence and Promotes Cancer by Targeting both p16(INK4A) and DNA Damage Pathways
por: Su, Weijun, et al.
Publicado: (2018)

X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution
por: Ziemniak, Marcin, et al.
Publicado: (2022)

Correction: X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution
por: Ziemniak, Marcin, et al.
Publicado: (2022)

Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44(+) Cells and Evidence for Epigenetic Mechanisms
por: Yan, Hong, et al.
Publicado: (2011)

Antibody Targeting of Eph Receptors in Cancer
por: Janes, Peter W., et al.
Publicado: (2020)

P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment
por: Mao, Chengqiong, et al.
Publicado: (2018)

Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor
por: Renfrow, Jaclyn J., et al.
Publicado: (2020)

Hypoxia Potentiates Glioma-Mediated Immunosuppression
por: Wei, Jun, et al.
Publicado: (2011)

Experimental and Computational Studies on Structure and Energetic Properties of Halogen Derivatives of 2-Deoxy-D-Glucose
por: Ziemniak, Marcin, et al.
Publicado: (2021)

Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme
por: Baharuddin, Wan Noor Ainun, et al.
Publicado: (2018)

Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates
por: Udompholkul, Parima, et al.
Publicado: (2021)

Eph receptors and ephrins as targets for cancer therapy
por: Xi, Hong-Qing, et al.
Publicado: (2012)

The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis
por: Carpenter, Richard L., et al.
Publicado: (2015)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells
por: Dong, Xiao-Dong, et al.
Publicado: (2023)

Eph receptors as oncotargets
por: Charmsaz, Sara, et al.
Publicado: (2017)

Eph Receptors in Cancer
por: Arora, Sakshi, et al.
Publicado: (2023)

Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors
por: Janes, Peter W., et al.
Publicado: (2011)

EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
por: Wang, Shervin D., et al.
Publicado: (2012)

Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors
por: Gmeiner, William H., et al.
Publicado: (2013)

Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ktikvr85dqd6tndnrdp8j66eiu